The potential public health impact of Herpes Zoster vaccination in the 65 years of age cohort in Italy

Herpes Zoster (HZ) presents a considerable public health burden in Italy among people aged ≥50 years. This study aimed to assess the clinical and economic impact of HZ vaccination in the 65 years of age (YOA) cohort in Italy, by comparing the new Adjuvanted Recombinant Zoster Vaccine (RZV) with the...

Descripción completa

Detalles Bibliográficos
Autores principales: Volpi, Antonio, Boccalini, Sara, Dari, Silvia, Clarke, Christopher, Curran, Desmond, Loiacono, Idalba, Pitrelli, Andrea, Puggina, Anna, Tosatto, Roberta, Van Oorschot, Desirée, Franco, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062451/
https://www.ncbi.nlm.nih.gov/pubmed/31442095
http://dx.doi.org/10.1080/21645515.2019.1657753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062451/
https://www.ncbi.nlm.nih.gov/pubmed/31442095
http://dx.doi.org/10.1080/21645515.2019.1657753

Ejemplares similares